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ABSTRACT The overall structure of transfer RNA is op-
timized for its various functions by a series of unique post-
transcriptional nucleotide modifications. Since many of these
modifications are conserved from prokaryotes through higher
eukaryotes, it has been proposed that most modified nucleotides
serve to optimize the ability of the tRNA to accurately interact
with other components of the protein synthesizing machinery.
When a cloned synthetic Escherichia coli tRNAIhe gene was
transfected into a bacterial host that carried a defective phen-
ylalanine tRNA-synthetase gene, tRNAPhe was overexpressed by
11-fold. As a result of this overexpression, an undermodified
tRNAPhe species was produced that lacked only N6-(A2-
isopentenyl)-2-methylthioadenosine (ms2i6A), a hypermodified
nucleotide found immediately 3' to the anticodon of all major E.
coli tRNAs that read UNN codons. To investigate the role of
ms2i6A in E. coli tRNA, we compared the aminoacylation
kinetics and in vitro codon-reading properties of the ms2i6A-
lacking and normal fully modified tRNAme species. The results
of these experiments indicate that while ms2i6A is not required
for normal aminoacylation of tRNAPhe, its presence stabilizes
codon-anticodon interaction and thereby prevents misreading of
the genetic code.
In 1973, Jukes (1) proposed that a hypermodification of the
nucleotide immediately 3' to the anticodon in transfer RNA
serves to ensure the fidelity of protein synthesis by prevent-
ing wobble base-pairing interactions between the third anti-
codon and first codon position nucleotides. This hypothesis
was based on the observation that all major tRNAs that read
codons beginning in A or U contain, with the exception of
Escherichia coli tRNAfmet, a hypermodified purine nucleo-
tide following the anticodon sequence (see ref. 2). Accord-
ingly, it was suggested that this anticodon-adjacent hyper-
modification stabilizes the relatively weak A-U/U-A base
pairings and thereby prevents misreading of the genetic code
(2). The classic exception to this pattern, E. coli tRNAfet,
contains an unmodified adenine immediately 3' to its antic-
odon and is able to read the codons GUG (valine) and UUG
(leucine) by a third anticodon position wobble mechanism, as
well as the AUG (methionine) codon by Watson-Crick base
pairing (1, 3, 4). The proposed restricted codon reading by the
hypermodified nucleotide 3' to the anticodon was further
supported upon examining the three-dimensional crystal
structure of yeast tRNAPhe (5). Here, it was determined that
the three anticodon and two distal nucleotides were stacked
in a continuous helix on one side of the anticodon loop, with
the first position or wobble nucleotide (6) at the bottom or 5'
end of the stack (5, 7). These observations suggested that the
hypermodified purine immediately 3' to the anticodon stabi-
lizes the helical stacking interaction and thus prevents the
third anticodon position nucleotide from participating in
wobble interactions with the first nucleotide of the codon (2,
8). In contrast, analysis of the three-dimensional crystalline
structure of E. coli tRNAfleS showed that the lack of a
hypermodified nucleotide immediately 3' to the anticodon
results in an altered stacking pattern of the loop nucleotides
and possibly a conformation that allows third anticodon
position wobble (9).
The pattern of anticodon-adjacent nucleotide hypermodi-
fication also is seen in the tRNAs from higher vertebrate
mitochondria, since mitochondrial tRNAs that read codons
starting with A or U contain N6-(A2-isopentenyl)-2-
methylthioadenosine (ms2i6A) or N-(9-3-D-ribofuranosylpu-
rin-6-ylcarbamoyl)threonine (t6A) immediately 3' to their
anticodons (10, 11). A single exception to this pattern has
been observed in the bovine mitochondrial tRNALeU (UUR),
which contains an unmodified adenine immediately following
its anticodon sequence (12). Since tRNAI'U (UUR) would
read the alternative CUR leucine codons via a third anticodon
position wobble mechanism, the lack of hypermodification of
its anticodon-adjacent purine does not result in misincorpo-
ration through codon misreading.
Previous studies of hypermodified nucleotide function in
tRNA have included detailed investigations of the role of
ms2i6A in E. coli tRNAPhe and tRNATyr in the aminoacyl
tRNA-synthetase reaction and in vitro polymer-dependent
protein synthesis (8, 13-15). These studies suggested that the
lack of ms2i6A did not decrease the ability of the tRNA to be
charged with its cognate amino acid but did alter the effi-
ciency with which the tRNA bound to the ribosome (13). In
addition, physical-biochemical studies have demonstrated
that the presence of various hypermodified nucleotides alters
the rigidity of dinucleotides in solution (8). These results are
consistent with the hypothesis that one major function of
ms2i6A (or t6A, for that matter) is to stabilize the stacking
interactions of the anticodon loop helix and thereby prevent
codon misreading. Furthermore, E. coli and Salmonella
typhimurium mia- mutants whose tRNAs are deficient in
ms2i6A have been observed to grow significantly slower than
wild-type strains (16, 17) and produce proteins with a lower
error frequency (18-21). Thus, it has been proposed that
tRNA species that possess the proper nucleotide modifica-
tion immediately 3' to the anticodon may be preferentially
used over the undermodified species in protein synthesis (22,
23).
In this present work, we obtained in vivo overexpression of
a cloned E. coli tRNAPhe gene and as a result could purify
large amounts of both the normal fully modified tRNAPhe
species and a second tRNAPhe species that lacked the
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hypermodified nucleotide ms2i6A and contained an unmodi-
fied adenine immediately 3' to the anticodon sequence but
was otherwise fully modified. After determining that both
homogenic tRNAIPhe species had identical aminoacylation
kinetics, we used a coupled in vitro transcription and trans-
lation system and radiolabeled protein sequencing to obtain
direct evidence that the presence ofms2i6A in E. coli tRNAPhe
prevents deleterious wobble base pairings between the third
anticodon and first codon position nucleotides during the
course of protein synthesis.
MATERIALS AND METHODS
Bacterial Strains and Plasmids. The isolation and nucleo-
tide sequence ofthe E. colipheUgenehas been reported (24).
The pheU gene-containing plasmid pRK3 has been redesig-
nated pRKU. The E. coli hosts, Hb-101 and NP-37, also have
been described (24, 25). The pAEPhe plasmid contains a
200-base-pair synthetic pheU gene, constructed from six
overlapping oligonucleotides cloned into the EcoRI and
HindIII sites of pAT153. All oligonucleotides were synthe-
sized on an Applied Biosystems 380ADNA synthesizer using
the modified cyanoethyl chemistry (26, 27).
Preparation and Fractionation of tRNA. Crude E. coli
tRNA was prepared by phenol extraction from late logarith-
mic-phase cultures (24). The tRNA was enriched for tRNA'.'
by passage over DEAE-cellulose (DE-52, Whatman) and
successively fractionated on an RPC-5 column (50 x 0.8 cm)
at pH 7.6, an Aminex-28 column (30 x 0.2 cm) at pH 4.5, and
a second RPC-5 column (30 x 0.2 cm) at pH 4.5 (28-30). This
method yielded tRNAPhC with an average purity of at least 1.2
nmol/A260e
Aminoacylation of tRNA I. Column fractions were as-
sayed for phenylalanine acceptor activity using a crude E.
coli aminoacyl tRNA-synthetase preparation (12 mg of pro-
tein per ml) and [U-14C]phenylalanine (50 ,uCi/mmol; 1 Ci =
37 GBq) (28, 31). Kinetic parameters of aminoacylation were
determined by using purified tRNAPbe as described (32).
tRNA Base Composition and Sequence Analysis. Base anal-
ysis of the purified tRNAPhC species was performed by the
postlabeling method of Randerath et al. (33). 3H-labeled
nucleoside diols were resolved by two-dimensional chroma-
tography on cellulose sheets in acetonitrile/ammonia/water
and Organic II/formic acid/water, respectively. Sequence
analysis of wild type and ms2i6A-lacking tRNAPhC species
was performed on 5' 32P-end-labeled tRNA by the method of
Gupta and co-workers (34). RPC-5 column-purified tRNAfhe
(10-15 ,ug) was electrophoresed on a 7 M urea/15% poly-
acrylamide gel and visualized by staining with 0.2%o methyl-
ene blue (pH 5.5). Full-length tRNA bands were elhted from
the gel, ethanol precipitated, and partially hydrolyzed in
deionized formamide at 960C for 7 min. The tRNA fragments
then were end-labeled, resolved on 7 M urea/15% polyacryl-
amide gels, and transferred to polyethyleneimine (PEI)-
cellulose thin-layer chromatography (TLC) sheets for one-
dimensional ascending chromatography in 0.55M ammonium
sulfate. The resulting chromatograms were autoradiographed
overnight at -700C to visualize the tRNA sequence. Modified
nucleotides were eluted from the PEI-cellulose TLC sheets
and further analyzed by two-dimensional TLC on Avicel
plates in isobutyric acid/ammonia/water and isopropanol/
HCl/water, respectively, with unlabeled nucleotide stan-
dards (33).
In Vitro Translation and Radiosequencing. In vitro protein
synthesis was performed using a previously described (35,
36), commercially available prokaryote DNA-dependent
translation system (Amersham) supplemented with pUC19
DNA, [ring-2,3,4,5,6-3H]phenylalanine (101 Ci/mmol), [U-
14C]leucine (348 mCi/mmol), the 18 other unlabeled amino
acids, and either purified tRNAIhe species at a 20-fold excess
over the endogenous tRNAPhC contained in the translation
system supplement (37). Radiosequencing of protein pro-
duced in the presence of a 20-fold excess of wild-type E. coli
tRNAPhC showed no significant misincorporation of phenyl-
alanine (see Fig. 2b). Alternatively, the system was supple-
mented with [U-'4C]phenylalanine (460 mCi/mmol) and
[3,4,5(N)-3H]leucine (140 Ci/mmol) to minimize isotopic
effects. The translation products initially were analyzed on
0.1% NaDodSO4/12.5% polyacrylamide gels. Subsequently,
the reaction products were purified to radiochemical homo-
geneity by S-200 chromatography and subjected to 20 cycles
of automated Edman degradation on a Beckman 890C se-
quenator using the dilute quadrol program (38). The radio-
activity in each sequenator cycle fraction then was measured
to determine phenylalanine and leucine incorporation at each
position.
RESULTS
Cloning and Expression of E. coli tRNAPh' Genes. A
3.6-kilobase-pair Sal I fragment containing the E. coli pheU
gene was excised from the pID2 plasmid (24), subcloned in
pBR322, and designated pRKU (previously designated pRK3
in ref. 24). A smaller version of the phetU operon was
constructed from six overlapping synthetic oligonucleotides
subcloned in pAT153 and designated pAEPhe. The construc-
tion strategy of this synthetic tRNA gene was similar to that
described by Normanly et al. (39) for a synthetic leucine
amber suppressor gene. However, the natural 5' and 3' pheU
flanking sequences were included so that transcription would
begin and terminate at the normal sites. Since we sought to
gain a greatly elevated level of expression of the cloned
tRNAPhC genes, we used the NP-37 host strain, which carries
a temperature-sensitive lesion in its phenylalanine tRNA-
synthetase (pheS) gene. When either version of the cloned,
tRNAPhe gene was introduced into the NP-37 strain, the
synthetase mutation was overcome and the host grew at the
nonpermissive temperature. As shown in Table 1, tempera-
ture resistance in NP-37 transformants was accompanied by
a large increase in the expression of tRNAPhe. Although the
precise mechanism behind the increased tRNAPhC production
is not understood, it has been speculated that increased levels
of tRNAPhe can compensate for an altered Km in the mutant
phenylalanine tRNA-synthetase produced by the E. coli
NP-37 host (27, 41).
Purification of Two tRNApt" Species. To determine whether
the greatly increased expression ofthe cloned E. colitRNA~he
genes resulted in the accumulation of both mature and
undermodified species, total tRNA was prepared from NP-37
transformants and partially fractionated by RPC-5 chroma-
tography (31). As shown in Fig. 1, NP-37/pAEPhe trans-
formants produced an elevated level of tRNAPhe, which
eluted at a position identical to the mature fully modified
Table 1. Comparison of in vitro amino acid acceptor levels
pmol/A260
Methionine Phenylalanine Phenylalanine
Strain (plasmid) (50 ACi/mmol) (50 pCi/mmol) overexpression
E. coli Hb-101 45.1 ± 4.1 40.1 + 6.1
Hb-101 (pRKU) 45.0 ± 4.0 68.2 ± 6.9 1.7
NP-37 (pRKU) 44.8 ± 4.0 461.2 ± 20.2 11.5
NP-37 (pRKW) (40) 44.9 ± 4.0 693.7 ± 15.5 17.3
NP-37 (pAEPhe) 44.7 ± 4.0 441.1 ± 15.5 11.0
Values represent an average of two independent assays in which
acceptor levels were determined in triplicate. Background (no tRNA)
was determined for each assay and subtracted to give corrected
values. Phenylalanine overexpression was calculated by dividing the
phenylalanine acceptor levels obtained by the value for E. coli
Hb-101.
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FIG. 1. Fractionation of total tRNA from E. coli Hb-101 (a) and
E. coli NP-37(pAEPhe) (b) on RPC-5. Elution of tRNA was moni-
tored by measuring the absorbance at 260 nm. Phenylalanine accep-
tor activity was determined by using crude E. coli aminoacyl
tRNA-synthetase as described in Materials and Methods.
tRNAPhe as well as a second earlier eluting species. An
identical chromatographic pattern was observed with tRNA
from NP-37/pRKU transformants (data not shown). Since
ms2i6A contains a large hydrophobic side chain that increases
the retention time of E. coli tRNAPhe on RPC-5, it was
suspected that the earlier eluting tRNAPhe species produced
by NP-37 transformants might contain an alternatively or
totally unmodified adenine nucleotide immediately 3' to the
anticodon. This suspicion was confirmed by postlabeling
nucleotide analysis and complete tRNA sequence determi-
nation of both tRNAPhe species (data not shown). These
sequencing studies demonstrated that the earlier eluting
tRNAPhe differed from the later eluting species only in that it
contained an unmodified adenine instead of a ms2i6A imme-
diately 3' to its anticodon. These experiments also showed
that both tRNAPhespecies produced by NP-37 transformants
had identical primary nucleotide sequences and contained
their full compliment of all other modified nucleotides.
Aminoacylation Kinetics of ns2i6A-Lacking tRNAPh. To test
whether both ms2i6A-lacking and ms2i6A-containing E. coli
tRNAPhe species could be properly recognized by phenylala-
nine tRNA-synthetase and subsequently charged with their
cognate amino acid, their aminoacylation kinetics were deter-
mined. The apparent Km and Vmax of aminoacylation for the
ms2i6A-lacking and ms2i6A-containing E. coli tRNAPh' species
were 0.90 x 10-7 M and 0.86 x 10-7 M, and 0.54
,umol-min-1mg-1 and 0.48 pumol-min-1mg-1, respectively.
These results directly confirm the earlier conclusions of Yanof-
sky and Soll (42) and Goddard and Lowden (43) and are
consistent with the previous suggestion that the nucleotide
immediately 3' to the anticodon is not one of the primary sites
ofphenylalanine tRNA-synthetase recognition in tRNAPhe(32).
In Vitro Codon Reading Properties of ms2i'A-Lacking
tRNAP". To investigate the codon reading properties of both
the wild-type and ms2i6A-lacking E. coli tRNAPbe species, we
used an E. coli cell-free coupled transcription/translation
system primed with pUC19 plasmid DNA (35-37). Using this
approach, only the 1-lactamase gene carried on the pUC19
plasmid was transcribed and translated when a 20-fold excess
of either normal or ms2i6A-lacking tRNAPhe and [14C]phenyl-
alanine was incubated with an S30 extract ofE. coli K-12, and
the products were analyzed by NaDodSO4/polyacrylamide
gel electrophoresis (data not shown). To compare the codon
reading properties of the normal and ms2i6A-lacking E. coli
tRNA e species, f3-lactamase was synthesized in the pres-
ence of either tRNAM'e species with [3H]phenylalanine and
[14C]leucine. The translation products were purified to ra-
diochemical homogeneity by Sephacryl S-200 chromatogra-
phy and subjected to 20 cycles of automated Edman degra-
dation. By measuring the radioactivity present in each ofthe
first 20 sequenator cycle fractions, we determined the posi-
tional incorporation of phenylalanine and leucine in the
protein. As shown in Fig. 2a, the 3-lactamase protein
contains phenylalanine residues at positions 6, 13, 14, and 17
and leucine residues at positions 10 and 19 (44). The results
of a typical radiosequencing experiment, shown in Fig. 2b,
demonstrated that the normal E. coli tRNAPhe only incorpo-
rated phenylalanine in response to UUC and UUU phenyl-
alanine codons. In contrast, the results shown in Fig. 2c
demonstrate that the ms2i6A-lacking tRNAPhC species incor-
porated phenylalanine at the positions that correspond to the
leucine codons (CUU) as well as the normal phenylalanine
codons. Similar results were obtained when the labeled
amino acids were reversed to [14C]phenylalanine and [3H]-
leucine (Fig. 2d). Since no misincorporation ofphenylalanine
was observed when the wild-type tRNAlMe was used at a
20-fold excess over the endogenous tRNAPhC contained in the
translation system, it was concluded that the "double-
wobble" codon reading resulted primarily from the lack of
ms2i6A. Interestingly, none of the radiosequencing data
showed phenylalanine incorporation at codon 12, corre-
sponding to proline (CCC), suggesting that there was no
second position wobble.
DISCUSSION
Through these experiments, we have obtained direct evi-
dence that the presence of the hypermodified nucleotide
ms2i6A in the position immediately 3' to the anticodon in E.
coli tRNAPhe restricts codon reading in vitro by preventing a
wobble base pairing with the first position codon nucleotide.
Furthermore, when an unmodified adenine is present imme-
diately following the anticodon, recognition of the CUU
codons by tRNAPhe involves a double-wobble base pairing
mechanism because both the first and third nucleotides ofthe
codon are read by non-Watson-Crick base pairing interac-
tions. As previously discussed, earlier reports indicated that
the presence of the hypermodified nucleotide ms2i6A in
tRNAPhC and tRNATYr optimizes the interaction between the
tRNA and ribosomes, with the undermodified species being
less efficient in translating the proper codons (reviewed in
ref. 45). Although our positional label analysis experiments
showed that msi6A-lacking tRNAIhe can incorporate phenyl-
alanine in response toCUU (and presumably CUC) codons, we
also observed that the total phenylalanine incorporation was
lower when the in vitro transcription/translation system was
supplemented with the undermodified tRNA Me rather than the
normal fully modified tRNAI'be species (unpublished observa-
tion). This is consistent with earlier reports (8, 13-15). It also
should be noted that an aberrant protein produced in vivo by
incorporating an undesirable amino acid via the first position
wobble mechanism, such as may occur in ms2i6A-deficient
strains, may be rapidly degraded by the extremely active
Biochemistry: Wilson and Roe
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bacterial protein degradation pathway (reviewed in ref. 46).
Since such a degradative mechanism most likely is not active in
the in vitro system used here, it is likely that the decreased level
of phenylalanine incorporation is the result of a lower in vitro
translation rate due to less efficient codon-anticodon interac-
tions of the ms2i6A-lacking tRNAPhe (8, 13).
If we assume that our experiments have given insight into
one of the functions of nucleotide modifications immediately
3' to the anticodon, we must consider the naturally occurring
absence of modification in this position in at least two tRNAs,
the E. coli tRNASer species with GGA and CGA anticodons
(47). Since both of these tRNAs contain an unmodified
adenine immediately 3' to their anticodons rather than the
expected ms2i6A, we can speculate that their G+C-rich
anticodon sequence is such that the anticodon loop and stem
more readily assume a tertiary structure that mimics the
effect of ms2i6A and thereby prevents first codon position
wobble. This speculation is supported by anticodon-
anticodon hybridization experiments (referenced in ref. 46).
Interestingly the analogous eukaryote tRNAser species con-
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FIG. 2. (a) Nucleotide and amino
acid sequences of the pUC19-en-
coded amino terminus of 3-lactamase
(44). Phenylalanine and leucine
codons are highlighted. Results of ra-
diosequencing experiments: P-lacta-
mase was produced in the presence of
normal fully modified tRNAPhe (b)
and ms2i6A-lacking tRNAPhe (c and
d). Raw dpm of sequenator cycle
fractions are plotted versus the ami-
no-terminal sequence of /-lactamase.
In vitro transcription/translation re-
actions were performed as described
in Materials and Methods using
[3H]phenylalanine and [14C]leucine (b
and c) or [14C]phenylalanine and
[3H]leucine (d). Amino acids are des-
ignated by the single-letter code.
tain a hypermodified nucleotide, N6-isopentenyladenosine
(i6A), immediately 3' to their anticodons (2).
In an elegant series of competition experiments, Smith and
co-workers (22, 23) reported on the effect of hypomodification
of the 3' anticodon adjacent nucleotide in mammalian tRNAlhe
on altering the codon preference of the tRNA in an in vitro
hemoglobin protein synthesis system (22, 23). Here, they
observed that the presence of m'G in place of the Y base at the
position immediately 3' to the anticodon in tRNAPhC resulted in
the preferential translation of the second of two adjacent
phenylalanine codons. In contrast, the fully modified tRNAPhe
species containing Y base preferentially translated the first of
the consecutive phenylalanine codons. There was, however, no
indication that the hypomodified mammalian tRNAPh' species
could read CUN codons by a third anticodon position wobble
mechanism. These observations, coupled with our results,
confirm the hypothesis that a major role of the modified
nucleotide immediately 3' to the anticodon in tRNA is to
modulate the tRNA's decoding properties. Our work extends
this hypothesis to the conclusion that the complete lack of
Proc. Natl. Acad. Sci. USA 86 (1989)
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modification of the 3' anticodon adjacent nucleotide allows for
misreading of the genetic code, a catastrophic event, which is
prevented from occurring in tumor cells by the presence of a
monomethylated guanosine in the hypomodified Y base-lacking
mammalian tRNAPbe (23).
The results of this presentwork also must be considered in
light of the earlier reports of the slower growth rate, slower
polypeptide step time, and reduced error frequency observed
both in vivo and in vitro for the E. coli and S. typhimurium
mia- mutants (16-21). As discussed above, our results are
consistent with the conclusion from these reports that the
lack of ms2i6A lowers the efficiency of cognate codon-
anticodon interactions and thus causes a reduced in vivo
growth rate through a slower polypeptide step time. How-
ever, Diaz et al. (20) reported that the ms2i6A-lacking
tRNA Leu species less efficiently misincorporates leucine in
response to the phenylalanine UUU codon in vitro, suggest-
ing that the ms2i6A-lacking tRNA4eU species is proofread
more efficiently than the ms2i6A-containing tRNA4eu wild-
type species. Although these results seemingly conflict with
our present studies, it should be pointed out that our results
were obtained when the in vitro protein synthesis system was
supplemented with either a 20-fold excess of the highly
purified ms2i6A-lacking or ms2i6A-containing tRNAPCh spe-
cies. Since our results and those reported by others (42, 43)
demonstrated that the aminoacylation kinetics for both
tRNAPhC species were identical, it can be assumed that the
ratio of ms2i6A-lacking/ms2i6A-containing tRNA Phe species
is 20:1 in the in vitro transcription/translation system. From
the experimental results shown in Fig. 2, it can be concluded
that phenylalanine is incorporated at both phenylalanine and
leucine codons in the presence of a 20-fold excess of the
ms2i6A-lacking tRNAPhe species, while no misincorporation
is observed in the presence of a 20-fold excess of the
ms2i6A-containing tRNAPhe species. Furthermore, misincor-
poration of phenylalanine in response to the leucine codons
occurs to an extent approximating 50% of the level of leucine
incorporation by the endogenous tRNALeU species. Thus,
although significantly less efficient, the ms2i6A-lacking
tRNAPhe species indeed will respond to the leucine codon and
misincorporate phenylalanine in these positions. Therefore,
we hypothesize that the increased proofreading of a mia-
tRNA at noncognate codons is made negligible by dramati-
cally increasing the absolute amount of ms2i6A-lacking tRNA
in the in vitro assay. This is supported by the fact that we
observed misincorporation of phenylalanine in response to
the leucine codon at approximately half ofthe level of leucine
incorporation at the same leucine codons when the ms2i6A-
lacking tRNAPhe was in 20-fold excess over either ms2i6A-
containing tRNAPhe or tRNALeU. Our observation that no
phenylalanine misincorporation into leucine codons occurred
when the ms2i6A-containing tRNAPhe was in -20-fold excess
over endogenous tRNALeU could be consistent with this
hypothesis if the anticodon loop stacking interactions are
enhanced by the presence of ms2i6A, and misincorporation
due to first position wobble is thereby reduced below a
measurable level.
Therefore, our present results support the notion that
ms2i6A in E. coli tRNAPhe plays a major role in preventing
misreading of the genetic code by restricting first codon
position wobble and enhancing cognate codon-anticodon
interactions. The generalized presence of hypermodified
nucleotides immediately 3' to a tRNA's anticodon therefore
may provide a more efficient mechanism for preventing
protein synthesis errors and thus endow the cell with an
evolutionary selective advantage. Furthermore, as originally
suggested by Jukes (1), the appearance ofanticodon-adjacent
hypermodification may have coincided with the expansion of
the genetic code from 10 to 18 amino acids, thus increasing
the potential for diversity among proteins.
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